GLP-1 Sub-PortalTirzepatide Clinical Protocols
Tirzepatide Clinical Research Guide & Titration Engine
Explore complete pharmacology, 16-24 week escalation ramps, and reconstitution math for Tirzepatide.
OE
Written by OnePeptideShip Editorial Team
Reviewed by Dr. Aris Thorne, MD, Board Certified Endocrinology Advisor
Updated September 2026
Tirzepatide Reconstitution Calculator
Convert mg to U-100 syringe units instantly.
GLP-1 Titration Engine
Dose Escalation Schedule Generator
Dual GIP/GLP-1 receptor agonist 4-week step-up schedule.
Visual Dose Ramp Schedule (Tirzepatide)
Weeks 1-4: 2.5 mg (Once weekly)Initiation dose
2.5 mg
Weeks 5-8: 5 mg (Once weekly)First therapeutic escalation
5 mg
Weeks 9-12: 7.5 mg (Once weekly)Step-up option
7.5 mg
Weeks 13-16: 10 mg (Once weekly)Mid-high target
10 mg
Weeks 17-20: 12.5 mg (Once weekly)Advanced target
12.5 mg
Weeks 21-24: 15 mg (Once weekly)Maximum study dose
15 mg
| Timeline | Dose (mg) | Frequency | Protocol Phase |
|---|---|---|---|
| Weeks 1 - 4 | 2.5 mg | Once weekly | Initiation dose |
| Weeks 5 - 8 | 5 mg | Once weekly | First therapeutic escalation |
| Weeks 9 - 12 | 7.5 mg | Once weekly | Step-up option |
| Weeks 13 - 16 | 10 mg | Once weekly | Mid-high target |
| Weeks 17 - 20 | 12.5 mg | Once weekly | Advanced target |
| Weeks 21 - 24 | 15 mg | Once weekly | Maximum study dose |
Frequently Asked Questions
Clinical paradigms recommend initiating at a low dose for 4 weeks before escalating to allow physiological acclimation and reduce gastrointestinal events.
Use our pre-configured Tirzepatide Reconstitution Calculator to input your vial mg and BAC water volume.